Literature DB >> 22997098

Proteomic features of potential tumor suppressor NESG1 in nasopharyngeal carcinoma.

Zhen Liu1, Chao Chen, Huiling Yang, Yajie Zhang, Jie Long, Xiaobin Long, Weiyi Fang.   

Abstract

We previously defined the recently revised NESG1 gene as a potential tumor suppressor in nasopharyngeal carcinoma (NPC). Here, we further used proteomics technology to globally examine NESG1-controlled proteins in NPC cells. Twenty-six proteins were found to be deregulated by NESG1 using proteomics analysis while enolase 1 (alpha) (ENO1), heat shock protein 90 kDa beta (Grp94), member 1 (HSP90B1), and cathepsin D (CTSD) proteins were differentially expressed by Western blot. Interestingly, a-enolase (ENO1), an overexpressed gene in NPC, was confirmed as a NESG1-regulated protein in NPC cells. Overexpressed ENO1 not only restored cell proliferation and cell-cycle progression, but also antagonized the regulation of NESG1 to cell-cycle regulators p21 and CCNA1 expression as well as induced the expression of C-Myc, pRB, and E2F1 in NESG1-ovexpressed NPC cells. Real-time PCR and immunohistochemistry analysis showed that NESG1 expression is negatively correlated with ENO1 expression in NPC tissues. Our observations suggest that ENO1 downregulation plays an important role in NESG1-induced growth inhibition of NPC cancer cells.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997098     DOI: 10.1002/pmic.201200146

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  7 in total

1.  Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.

Authors:  Qiao-Fen Fu; Yan Liu; Yue Fan; Sheng-Ni Hua; Hong-Ying Qu; Su-Wei Dong; Rui-Lei Li; Meng-Yang Zhao; Yan Zhen; Xiao-Li Yu; Yi-Yu Chen; Rong-Cheng Luo; Rong Li; Li-Bo Li; Xiao-Jie Deng; Wei-Yi Fang; Zhen Liu; Xin Song
Journal:  J Hematol Oncol       Date:  2015-03-08       Impact factor: 17.388

Review 2.  A Review: Proteomics in Nasopharyngeal Carcinoma.

Authors:  Ze-Tan Chen; Zhong-Guo Liang; Xiao-Dong Zhu
Journal:  Int J Mol Sci       Date:  2015-07-08       Impact factor: 5.923

3.  Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.

Authors:  De Tao Yin; Jianhui Xu; Mengyuan Lei; Hongqiang Li; Yongfei Wang; Zhen Liu; Yubing Zhou; Mingzhao Xing
Journal:  Oncotarget       Date:  2016-02-02

4.  Expression of Coiled-Coil Domain Containing 34 (CCDC34) and its Prognostic Significance in Pancreatic Adenocarcinoma.

Authors:  Wei Qi; Feng Shao; Qiang Huang
Journal:  Med Sci Monit       Date:  2017-12-19

5.  VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

Authors:  Yingxia Ning; Zhaoyang Zeng; Yuao Deng; Weifeng Feng; Lun Huang; Huiling Liu; Jiazhi Lin; Chen Zhang; Yue Fan; Longyang Liu
Journal:  Cancer Sci       Date:  2021-03-31       Impact factor: 6.716

6.  microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.

Authors:  Yiyu Chen; Jingwen Jiang; Mengyang Zhao; Xiaojun Luo; Zixi Liang; Yan Zhen; Qiaofen Fu; Xiaojie Deng; Xian Lin; Libo Li; Rongcheng Luo; Zhen Liu; Weiyi Fang
Journal:  Oncotarget       Date:  2016-07-05

Review 7.  Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer.

Authors:  Ramon Yarza; Mateo Bover; Maria Teresa Agulló-Ortuño; Lara Carmen Iglesias-Docampo
Journal:  J Exp Clin Cancer Res       Date:  2021-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.